These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3140617)

  • 1. Modulation of arachidonic acid metabolites as potential therapy of asthma.
    Wasserman MA
    Agents Actions Suppl; 1988; 23():95-111. PubMed ID: 3140617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the role of PGD2 metabolites as markers of mast cell activation in asthma.
    O'Sullivan S
    Acta Physiol Scand Suppl; 1999 Apr; 644():1-74. PubMed ID: 10352758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arachidonic acid metabolites: mediators of inflammation in asthma.
    Wenzel SE
    Pharmacotherapy; 1997; 17(1 Pt 2):3S-12S. PubMed ID: 9017783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoxygenase pathway and hydroperoxy acids: possible relevance to aspirin-induced asthma and hyperirritability of airways in asthmatics.
    Chand N; Altura BM
    Prostaglandins Med; 1981 Feb; 6(2):249-56. PubMed ID: 6113615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediators of hypersensitivity and inflammatory cells in the pathogenesis of bronchial asthma.
    Kay AB
    Eur J Respir Dis Suppl; 1983; 129():1-44. PubMed ID: 6418559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arachidonic acid derivatives as mediators of asthma.
    Lewis RA; Robin JL
    J Allergy Clin Immunol; 1985 Aug; 76(2 Pt 2):259-64. PubMed ID: 3926852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4, and E4.
    Dahlén SE; Hansson G; Hedqvist P; Björck T; Granström E; Dahlén B
    Proc Natl Acad Sci U S A; 1983 Mar; 80(6):1712-6. PubMed ID: 6300870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of prostaglandins and leukotrienes by human lung tissue in vitro after activation by the calcium ionophore A23187.
    Zijlstra FJ; Naaktgeboren M; Mons H; Vincent JE
    Eur J Clin Invest; 1987 Aug; 17(4):325-9. PubMed ID: 2822430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction.
    O'Sullivan S; Dahlén B; Dahlén SE; Kumlin M
    J Allergy Clin Immunol; 1996 Aug; 98(2):421-32. PubMed ID: 8757220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].
    Fal AM; Kopeć A
    Pneumonol Alergol Pol; 2010; 78(1):68-73. PubMed ID: 20162521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacology of leukotrienes in human airways: in vitro and in vivo studies.
    Viganó T; Crivellari MT; Civelli M; Oliva D; Nicosia S; Miadonna A; Tedeschi A; Sala A; Folco GC
    Eur Respir J Suppl; 1989 Jun; 6():488s-492s. PubMed ID: 2803405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma.
    Devillier P; Baccard N; Advenier C
    Pharmacol Res; 1999 Jul; 40(1):3-13. PubMed ID: 10378985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between mediator release from human lung mast cells in vitro and in vivo.
    Holgate ST; Benyon RC; Howarth PH; Agius R; Hardy C; Robinson C; Durham SR; Kay AB; Church MK
    Int Arch Allergy Appl Immunol; 1985; 77(1-2):47-56. PubMed ID: 2409026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of lipid mediators in asthma (current views and perspectives).
    König W; Schönfeld W; Knöller J; Köller M
    Allergol Immunopathol (Madr); 1988; 16(5):289-98. PubMed ID: 3147587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukotrienes and prostaglandins in asthma.
    Bisgaard H
    Allergy; 1984 Aug; 39(6):413-20. PubMed ID: 6208802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergen-stimulated release of mediators into sheep bronchoalveolar lavage fluid. Effect of cyclooxygenase inhibition.
    Dworski R; Sheller JR; Wickersham NE; Oates JA; Brigham KL; Roberts LJ; Fitzgerald GA
    Am Rev Respir Dis; 1989 Jan; 139(1):46-51. PubMed ID: 2492175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary intravascular macrophages metabolize arachidonic acid in vitro. Comparison with alveolar macrophages.
    Bertram TA; Overby LH; Danilowicz R; Eling TE; Brody AR
    Am Rev Respir Dis; 1988 Oct; 138(4):936-44. PubMed ID: 2849345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arachidonic acid metabolism in cultured alveolar macrophages from normal, atopic, and asthmatic subjects.
    Balter MS; Eschenbacher WL; Peters-Golden M
    Am Rev Respir Dis; 1988 Nov; 138(5):1134-42. PubMed ID: 3144211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Leukotrienes].
    Sirois P; Borgeat P
    Sem Hop; 1984 Mar; 60(14):979-85. PubMed ID: 6326287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of cyclooxygenase products in the acute airway obstruction and airway hyperreactivity of ponies with heaves.
    Gray PR; Derksen FJ; Robinson NE; Carpenter-Deyo LJ; Johnson HG; Roth RA
    Am Rev Respir Dis; 1989 Jul; 140(1):154-60. PubMed ID: 2502051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.